253 related articles for article (PubMed ID: 20558610)
1. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2.
Meeths M; Entesarian M; Al-Herz W; Chiang SC; Wood SM; Al-Ateeqi W; Almazan F; Boelens JJ; Hasle H; Ifversen M; Lund B; van den Berg JM; Gustafsson B; Hjelmqvist H; Nordenskjöld M; Bryceson YT; Henter JI
Blood; 2010 Oct; 116(15):2635-43. PubMed ID: 20558610
[TBL] [Abstract][Full Text] [Related]
2. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.
Rohr J; Beutel K; Maul-Pavicic A; Vraetz T; Thiel J; Warnatz K; Bondzio I; Gross-Wieltsch U; Schündeln M; Schütz B; Woessmann W; Groll AH; Strahm B; Pagel J; Speckmann C; Janka G; Griffiths G; Schwarz K; zur Stadt U; Ehl S
Haematologica; 2010 Dec; 95(12):2080-7. PubMed ID: 20823128
[TBL] [Abstract][Full Text] [Related]
3. Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia.
Esmaeilzadeh H; Bemanian MH; Nabavi M; Arshi S; Fallahpour M; Fuchs I; zur Stadt U; Warnatz K; Ammann S; Ehl S; Lehmberg K; Rezaei N
J Clin Immunol; 2015 Jan; 35(1):22-5. PubMed ID: 25491289
[TBL] [Abstract][Full Text] [Related]
4.
Benavides N; Spessott WA; Sanmillan ML; Vargas M; Livingston MS; Erickson N; Pozos TC; McCormick ME; Scharrig E; Messinger YH; Giraudo CG
Front Immunol; 2020; 11():545414. PubMed ID: 33162974
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.
Spessott WA; Sanmillan ML; McCormick ME; Patel N; Villanueva J; Zhang K; Nichols KE; Giraudo CG
Blood; 2015 Mar; 125(10):1566-77. PubMed ID: 25564401
[TBL] [Abstract][Full Text] [Related]
6. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes.
Nagai K; Yamamoto K; Fujiwara H; An J; Ochi T; Suemori K; Yasumi T; Tauchi H; Koh K; Sato M; Morimoto A; Heike T; Ishii E; Yasukawa M
PLoS One; 2010 Nov; 5(11):e14173. PubMed ID: 21152410
[TBL] [Abstract][Full Text] [Related]
7. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).
Pagel J; Beutel K; Lehmberg K; Koch F; Maul-Pavicic A; Rohlfs AK; Al-Jefri A; Beier R; Bomme Ousager L; Ehlert K; Gross-Wieltsch U; Jorch N; Kremens B; Pekrun A; Sparber-Sauer M; Mejstrikova E; Wawer A; Ehl S; zur Stadt U; Janka G
Blood; 2012 Jun; 119(25):6016-24. PubMed ID: 22451424
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis.
Viñas-Giménez L; Rincón R; Colobran R; de la Cruz X; Celis VP; Dapena JL; Alsina L; Sayós J; Martínez-Gallo M
Front Immunol; 2021; 12():723836. PubMed ID: 34630398
[TBL] [Abstract][Full Text] [Related]
9. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5.
Cetica V; Santoro A; Gilmour KC; Sieni E; Beutel K; Pende D; Marcenaro S; Koch F; Grieve S; Wheeler R; Zhao F; zur Stadt U; Griffiths GM; Aricò M
J Med Genet; 2010 Sep; 47(9):595-600. PubMed ID: 20798128
[TBL] [Abstract][Full Text] [Related]
10. [Natural killer cell cytotoxic activity in critical pediatric patients with suspected hemophagocytic syndrome].
Martínez I; Fernández L; Valentín J; Castillo C; Chamorro C; Pérez-Martínez A
Med Intensiva; 2015 May; 39(4):213-21. PubMed ID: 25081072
[TBL] [Abstract][Full Text] [Related]
11. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells.
Côte M; Ménager MM; Burgess A; Mahlaoui N; Picard C; Schaffner C; Al-Manjomi F; Al-Harbi M; Alangari A; Le Deist F; Gennery AR; Prince N; Cariou A; Nitschke P; Blank U; El-Ghazali G; Ménasché G; Latour S; Fischer A; de Saint Basile G
J Clin Invest; 2009 Dec; 119(12):3765-73. PubMed ID: 19884660
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2.
Seo JY; Lee KO; Yoo KH; Sung KW; Koo HH; Kim SH; Kang HJ; Park KD; Shin HY; Baek HJ; Kook H; Lyu CJ; Song JS; Lee MJ; Kim JY; Lim YT; Koh KN; Im HJ; Seo JJ; Kim HJ;
Clin Genet; 2016 Feb; 89(2):222-7. PubMed ID: 26451869
[TBL] [Abstract][Full Text] [Related]
13. Different Clinical Presentation of 3 Children With Familial Hemophagocytic Lymphohistiocytosis With 2 Novel Mutations.
Akyol S; Ozcan A; Sekine T; Chiang SCC; Yilmaz E; Karakurkcu M; Patiroglu T; Bryceson Y; Unal E
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e627-e629. PubMed ID: 31651726
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity.
Viñas-Giménez L; Donadeu L; Alsina L; Rincón R; de la Campa EÁ; Esteve-Sole A; Català A; Colobran R; de la Cruz X; Sayós J; Martínez-Gallo M
Int J Hematol; 2020 Mar; 111(3):440-450. PubMed ID: 31865540
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic defects in erythroid cells from familial hemophagocytic lymphohistiocytosis type 5 patients identify a role for STXBP2/Munc18-2 in erythropoiesis and phospholipid scrambling.
Kostova EB; Beuger BM; Veldthuis M; van der Werff Ten Bosch J; Kühnle I; van den Akker E; van den Berg TK; van Zwieten R; van Bruggen R
Exp Hematol; 2015 Dec; 43(12):1072-1076.e2. PubMed ID: 26320718
[TBL] [Abstract][Full Text] [Related]
16. Familial Hemophagocytic Lymphohistiocytosis secondary to UNC13D mutation: a report of two cases.
Sadeghi P; Esslami GG; Rokni-Zadeh H; Changi-Ashtiani M; Mohsenipour R
BMC Pediatr; 2022 Nov; 22(1):667. PubMed ID: 36401200
[TBL] [Abstract][Full Text] [Related]
17. Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations.
Zhao XW; Gazendam RP; Drewniak A; van Houdt M; Tool AT; van Hamme JL; Kustiawan I; Meijer AB; Janssen H; Russell DG; van de Corput L; Tesselaar K; Boelens JJ; Kuhnle I; Van Der Werff Ten Bosch J; Kuijpers TW; van den Berg TK
Blood; 2013 Jul; 122(1):109-11. PubMed ID: 23687090
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity.
Saltzman RW; Monaco-Shawver L; Zhang K; Sullivan KE; Filipovich AH; Orange JS
J Allergy Clin Immunol; 2012 Jun; 129(6):1666-8. PubMed ID: 22336081
[TBL] [Abstract][Full Text] [Related]
19. Novel STXBP2 mutation causing familial hemophagocytic lymphohistiocytosis.
Jain R; Puliyel M; Moses PD; Sieni E
Indian Pediatr; 2012 Jun; 49(6):488-90. PubMed ID: 22796692
[TBL] [Abstract][Full Text] [Related]
20. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.
zur Stadt U; Rohr J; Seifert W; Koch F; Grieve S; Pagel J; Strauss J; Kasper B; Nürnberg G; Becker C; Maul-Pavicic A; Beutel K; Janka G; Griffiths G; Ehl S; Hennies HC
Am J Hum Genet; 2009 Oct; 85(4):482-92. PubMed ID: 19804848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
